Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Mediferrotit AB
AB
Active
Org 5590012000
Ranunkelgatan 1 A, 431 32
Mölndal
Engineering activities and related technical consultancy
· NACE 7112
Est. 2015
1 employees
Watchlist
Share
Sweden
/
Companies
/
Engineering activities and related technical consultancy
/
Mediferrotit AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 492
1 318
933
1 193
583
Staff expenses
—
—
—
—
—
EBITDA
633
752
50
125
−50
Depreciation & amort.
−23
−11
−0
−0
−0
EBIT
610
741
50
125
−50
Net financials
—
—
−1
−2
1
Profit before tax
456
553
126
88
104
Tax
−98
−114
−29
−20
−24
Net profit
358
439
97
68
80
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 304
1 441
847
991
839
Equity
570
609
207
274
354
Long-term debt
0
0
0
0
0
Short-term debt
455
369
258
302
226
Total debt
455
369
258
302
226
Financial ratios
5-year trend
EBITDA margin
-8.6%
This company
15.8%
Market median
-154% vs market
2021
2025
Equity ratio
42.2%
This company
38.2%
Market median
+10% vs market
2021
2025
Return on equity
22.6%
This company
18.4%
Market median
+23% vs market
2021
2025
Net profit margin
13.7%
This company
8.1%
Market median
+69% vs market
2021
2025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
2021
2025
Debt / equity
1.37×
This company
0.62×
Market median
-121% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on Mediferrotit AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network